Company intelligence
Hongene Biotech Corporation
A manufacturer with state-of-art facilities in the fields of nucleosides, nucleotides and phosphoramidites
About Hongene Biotech Corporation
Hongene is a vertically integrated nucleic acid CDMO and specialist raw materials supplier supporting the development and manufacture of oligonucleotide and mRNA-based therapeutics. With nearly three decades of RNA-focused experience, we offer fully integrated capabilities spanning critical raw materials, oligonucleotide and mRNA drug substance and drug product. By uniting raw material synthesis with cGMP manufacturing under one roof, we minimize handoffs, support consistent quality, and help customers move faster from development to market. We serve biotech and pharma partners in the US, Europe, Asia, and beyond, combining deep nucleic acid specialization with a commitment to innovation and environmental sustainability. Continuously innovating to make RNA medicines accessible and affordable for patients worldwide.
Verified activity
Signals from Hongene Biotech Corporation
3 published signals
Products & Services
Hongene Biotech Corporation published a new one-pager titled 'Vertically Integrated CDMO Capabilities at a Glance' detailing its vertically integrated supply model for nucleic acid therapeutics development.
Reported by Hongene Biotech Corporation
Products & Services
Hongene Biotech Corporation pioneers chemoenzymatic ligation technology to enable more sustainable production of next-generation RNA therapeutics.
Reported by Hongene Biotech Corporation
Research & Knowledge
Hongene Biotech Corporation's Advisor David Butler explores what this means for manufacturing in the latest issue of Innovations in Pharmaceutical Technology (IPT) regarding scaling oligonucleotide production.
Reported by Hongene Biotech Corporation